glutathione and triple negative breast cancer Metabolic interplay between exogenous cystine glutamine dependence in triple-negative Oncology Letters
Oncology Letters Heterogeneity and transcriptional drivers of triple negative breast cancer: Cell Reports GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect GPX4 Inhibitor Resistance and Metastatic Features in TripleNegative Breast Cancer Sabatier 2026 Advanced Science Wiley Online Library Frontiers Ferroptosis: the emerging player in remodeling triple negative breast cancer NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene
Pay in 4 interest-free payments of $5.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





